Laporan Laba Rugi (TTM)
Laporan Laba Rugi Pell Bio-Med Technology Co., Ltd. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.
Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.
|
2021 12-31 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 14 | 17 | 19 | 20 | 20 | 18 | 18 | 18 | 18 | 20 | 27 | 27 |
| Change (%) | 22.75 | 8.15 | 7.13 | 2.62 | -11.60 | -0.37 | 0.13 | 2.35 | 6.62 | 35.38 | 3.22 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 18 | 28 | 29 | 37 | 45 | 44 | 45 | 38 | 31 | 32 | 32 | 33 |
| Change (%) | 54.87 | 0.93 | 28.99 | 21.70 | -1.88 | 2.61 | -15.38 | -19.61 | 3.64 | -1.12 | 3.76 | |
| % of Revenue | 131.27 | 165.61 | 154.55 | 186.09 | 220.70 | 244.96 | 252.30 | 213.22 | 167.47 | 162.79 | 118.90 | 119.52 |
| Gross Operating Profit | -4 | -11 | -10 | -17 | -25 | -26 | -27 | -20 | -12 | -12 | -5 | -5 |
| Change (%) | 157.60 | -10.08 | 69.07 | 43.87 | 6.17 | 4.67 | -25.56 | -39.01 | -0.77 | -59.24 | 6.61 | |
| % of Revenue | -31.27 | -65.61 | -54.55 | -86.09 | -120.70 | -144.96 | -152.30 | -113.22 | -67.47 | -62.79 | -18.90 | -19.52 |
| SG&A | 55 | 82 | 88 | 115 | 134 | 145 | 158 | 148 | 137 | 135 | 137 | 137 |
| Change (%) | 50.26 | 7.31 | 29.95 | 16.46 | 8.85 | 8.62 | -6.31 | -7.75 | -1.16 | 1.38 | 0.40 | |
| % of Revenue | 391.90 | 479.71 | 475.98 | 577.36 | 655.23 | 806.81 | 879.62 | 823.06 | 741.85 | 687.74 | 515.03 | 500.98 |
| R&D | 137 | 143 | 146 | 187 | 212 | 240 | 254 | 256 | 261 | 266 | 268 | 238 |
| Change (%) | 4.19 | 2.28 | 28.07 | 13.59 | 12.97 | 6.13 | 0.72 | 1.91 | 1.96 | 0.53 | -10.98 | |
| % of Revenue | 978.87 | 830.84 | 785.77 | 939.34 | 1,039.81 | 1,328.75 | 1,415.48 | 1,423.85 | 1,417.72 | 1,355.81 | 1,006.82 | 868.30 |
| OpEx | 210 | 253 | 263 | 338 | 391 | 429 | 458 | 443 | 428 | 433 | 436 | 408 |
| Change (%) | 20.64 | 3.77 | 28.80 | 15.45 | 9.85 | 6.61 | -3.30 | -3.19 | 1.09 | 0.67 | -6.34 | |
| % of Revenue | 1,502.03 | 1,476.17 | 1,416.30 | 1,702.79 | 1,915.74 | 2,380.52 | 2,547.40 | 2,460.14 | 2,327.04 | 2,206.35 | 1,640.75 | 1,488.81 |
| Operating Income | -196 | -236 | -244 | -319 | -370 | -411 | -440 | -425 | -410 | -413 | -409 | -381 |
| Change (%) | 20.49 | 3.45 | 30.45 | 16.25 | 11.03 | 6.92 | -3.44 | -3.42 | 0.84 | -0.97 | -6.96 | |
| % of Revenue | -1,402.03 | -1,376.17 | -1,316.30 | -1,602.79 | -1,815.74 | -2,280.52 | -2,447.40 | -2,360.14 | -2,227.04 | -2,106.35 | -1,540.75 | -1,388.81 |
| Interest Expense | -2 | -1 | -2 | -2 | -2 | -3 | -2 | -2 | -2 | -2 | -3 | -4 |
| Change (%) | -10.34 | 24.50 | 17.85 | 14.42 | 11.86 | -4.11 | -4.00 | -3.06 | -0.92 | 39.29 | 28.78 | |
| % of Revenue | -10.86 | -7.93 | -9.13 | -10.05 | -11.20 | -14.17 | -13.64 | -13.08 | -12.39 | -11.51 | -11.85 | -14.78 |
| Net Income | -189 | -230 | -238 | -310 | -361 | -399 | -425 | -404 | -386 | -389 | -380 | -356 |
| Change (%) | 21.79 | 3.55 | 30.03 | 16.51 | 10.45 | 6.54 | -4.96 | -4.34 | 0.83 | -2.45 | -6.25 | |
| % of Revenue | -1,351.93 | -1,341.32 | -1,284.26 | -1,558.76 | -1,769.81 | -2,211.26 | -2,364.57 | -2,244.37 | -2,097.55 | -1,983.67 | -1,429.44 | -1,298.29 |
Source: Capital IQ
